Gault Cheryl
SEC CIK 1839046 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | COO | 149.9K | — | $1.10M | 8 | 2025-03-03 | 2026-06-30 |
Most active insiders at RAPP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Third Rock Ventures V, L.P. | 10% | — | $34.39M |
| 2 | Ceesay Abraham | CEO, Dir | — | $6.07M |
| 3 | Yeleswaram Krishnaswamy | Chief Development Off | — | $4.46M |
| 4 | Bredt David | CSO | — | $1.36M |
| 5 | Gault Cheryl | COO | — | $906.4K |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-07-01 16:10 | 2026-06-30 | RAPP | Rapport Therapeutics, Inc. | Gault Cheryl | COO | S - Sale | $41.58 | -10.0K | 149.9K | -6% | -$415.8K |
| MT | 2026-03-31 | 2026-03-30 | RAPP | Rapport Therapeutics, Inc. | Gault Cheryl | COO | S - Sale | $28.18 | -10.0K | 159.9K | -6% | -$281.8K |
| 2026-03-09 | 2026-03-05 | RAPP | Rapport Therapeutics, Inc. | Gault Cheryl | COO | S - Sale | $28.93 | -2,014 | 169.9K | -1% | -$58.3K | |
| DT | 2025-12-01 | 2025-11-26 | RAPP | Rapport Therapeutics, Inc. | Gault Cheryl | COO | M - OptEx | $1.80 | +5,000 | 176.9K | +3% | +$9,000 |
| DT | 2025-12-01 | 2025-11-26 | RAPP | Rapport Therapeutics, Inc. | Gault Cheryl | COO | S - Sale+OE | $30.10 | -5,000 | 171.9K | -3% | -$150.5K |
| DT | 2025-09-10 | 2025-09-08 | RAPP | Rapport Therapeutics, Inc. | Gault Cheryl | COO | M - OptEx | $1.80 | +5,000 | 176.9K | +3% | +$9,000 |
| DT | 2025-09-10 | 2025-09-08 | RAPP | Rapport Therapeutics, Inc. | Gault Cheryl | COO | S - Sale+OE | $38.33 | -5,000 | 171.9K | -3% | -$191.7K |
| 2025-03-05 | 2025-03-03 | RAPP | Rapport Therapeutics, Inc. | Gault Cheryl | COO | A - Grant | $0.00 | +14.0K | 171.9K | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations